SG/CALL/INTUITIVE SURGICAL/230/0.1/21.06.24 Stock

Warrant

DE000SQ0V1N8

Delayed Deutsche Boerse AG 01:04:33 2024-06-10 pm EDT
17.32 EUR 0.00% Intraday chart for SG/CALL/INTUITIVE SURGICAL/230/0.1/21.06.24
Current month+11.03%
1 month+16.95%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-10 17.32 0.00%
24-06-07 17.32 +0.46%
24-06-06 17.24 +0.35%
24-06-05 17.18 +6.31%
24-06-04 16.16 +1.64%

Delayed Quote Deutsche Boerse AG

Last update June 10, 2024 at 01:04 pm EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying INTUITIVE SURGICAL, INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SQ0V1N
ISINDE000SQ0V1N8
Date issued 2022-09-23
Strike 230 $
Maturity 2024-06-21 (11 Days)
Parity 10 : 1
Emission price 3.89
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 17.56
Lowest since issue 3.2
Delta0x
Omega 0.000000
Premium0x
Gearing0x
Moneyness 1.810
Difference Strike -185.5 $
Difference Strike %-80.64%
Intrinsic value 17.27

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
417.6 USD
Average target price
423.6 USD
Spread / Average Target
+1.43%
Consensus